ELANE and colorectal carcinoma: This novel NE‐CREB1‐miR‐373 signaling axis may potentially serve as a new therapeutic target for CRC, which occurs commonly and is highly innervated by autonomic fibers, ultimately resulting in reduced patient survival (Liebl et al., 2013).